Clinical
Trials
Finder
Conditions
Drugs
Locations
Institutions
Guides
Search Trials
Get Alerts
Search
Conditions
Drugs
Locations
Institutions
Guides
Search Trials
Get Alerts
Conditions
Post-essential Thrombocythemia Myelofibrosis (PET-MF)
Seoul, Yangcheon Gu
Post-essential Thrombocythemia Myelofibrosis (PET-MF) Clinical Trials in Seoul, Yangcheon Gu
1 recruiting
Seoul, Yangcheon Gu, South Korea
Showing
1–1
of
1
trials
Recruiting
Phase 3
A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)
Primary myelofibrosis (PMF)
Post-polycythemia Vera Myelofibrosis (PPV-MF)
Post-essential Thrombocythemia Myelofibrosis (PET-MF)
Novartis Pharmaceuticals
460 enrolled
6 locations
NCT07357727
Feedback